Makers Laboratories Limited is engaged in the pharmaceuticals business. The Company's product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB (a-b Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also provides a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone) and Hypernorm range (Telmisartan). Its retail product range includes antibiotic range; cough and cold control; cardio-diabetic; anti-allergic; topical antibiotic/antimicrobial; neurotonic range, and anti-malarial. Its dispensing products include Coffwin-D Tablets, Chlorpheniramine Maleate 4 milligram (mg) Tablets, Betamethasone 0.5 mg Tablets and Ibuprofen 400 mg Tablets. It operates a distribution network of over 20 consignment agents and over 15 super stockiest, catering to stockiest, doctors and retailers.